By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
It has been a mixed year for Pfizer Inc insiders: $3 million bought by three people and $135,000 sold by one, so more buying than selling overall.
Biggest single buyer: BOURLA ALBERT, CEO, with roughly $1 million. Notably, at least one C-suite executive was among the buyers.
Zooming out by quarter: Last full quarter: net buying by insiders. Insiders bought in 2 of the last 7 full quarters. PFE also shows up in congressional disclosures: 34 reported trades from 17 lawmakers in two years. 2,823 investment managers listed PFE in their latest 13F filings (Q2 2026); funds were split between buying and selling.
Are insiders buying or selling PFE stock?
In the last 12 months Pfizer Inc insiders made open-market purchases worth about $3 million and sales worth about $135,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in PFE?
The most recent open-market insider trade in PFE was filed on 2026-08-12.
How many institutions own PFE?
2,823 investment managers reported holding PFE in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded PFE?
Yes. Members of Congress reported 34 trades in PFE over the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).